Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. INTC
8. JBLU
9. AAPL
10. NVDA

Go back to Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c

Chembio Diagnostics Reports Third Quarter 2016 Financial Results

November 10, 2016 8:50 AM EST

MEDFORD, N.Y., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today reported financial results for the three and nine months ended September 30, 2016.

John J. Sperzel III, Chief Executive Officer, stated, The Company made important advances in multiple areas during the third quarter of 2016, intended to prepare the Company for growth: commercialization, regulatory approvals, product development grants, and equity financing.  With respect to Chembio's commercial infrastructure, the Company appointed two seasoned executives to build our worldwide sales and marketing... More